title: Beta-blocker tolerability in elderly heart failure patients.
abstract: Beta-blocker therapy is well established for patients with chronic heart failure. In clinical practice, questions of tolerability and recommended target dose therapy remain important topics.
authors.forename: Hans-Dirk
authors.initials: HD
authors.lastname: Düngen
authors.forename: Felix
authors.initials: F
authors.lastname: Mehrhof
authors.forename: Svetlana
authors.initials: S
authors.lastname: Apostolović
authors.forename: Simone
authors.initials: S
authors.lastname: Inkrot
authors.forename: Rainer
authors.initials: R
authors.lastname: Dietz
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000367:Age Factors; D000368:Aged; D002986:Clinical Trials as Topic / Q000379:methods; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans
chemical_list: D000319:Adrenergic beta-Antagonists